SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-254565
Filing Date
2020-09-25
Accepted
2020-09-25 16:05:53
Documents
3
Effectiveness Date
2020-09-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d41001ddefa14a.htm DEFA14A 17464
2 GRAPHIC g41001g15w40.jpg GRAPHIC 35030
3 GRAPHIC g41001g52w77.jpg GRAPHIC 8119
  Complete submission text file 0001193125-20-254565.txt   78215
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38536 | Film No.: 201200193
SIC: 2834 Pharmaceutical Preparations